Skip to main content

Advertisement

Table 1 Inhibitors used in this study. Chemical structures of inhibitor used in this study tackling Menin-MLL1 interaction, BRD4/2/3, DOT1L, CDK9, and DHODH active sites, with respective biochemical IC50, rationale and current developmental status

From: Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia